Patents

US 12453752 B2: Hevamine-related plant compositions and methods

Granted
2025-10-28
Filed
2022-04-27 application 17660967
Type
Utility · 12 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present application relates to a compositions and methods comprising or expressing a hevamine A-related MoMo30 protein from Momordica balsamina. The MoMo30 protein is about 30 kDa in size, is stable after being autoclaved at 120° C. for 30 min, resists proteolytic cleavage by trypsin, exhibits mannose-sensitive binding to HIV gp120, exhibits hemagglutinin and chitinase activity, is capable of activating and stimulating T cell proliferation, is capable of preventing infection by HIV-1 or alleviating symptoms in an HIV-1 infected patients, and comprises an amino acid sequence of SEQ ID NO: 4. The MoMo30 protein and/or a nucleic acid encoding the same may be used in methods for preventing or treating microbial infections by HIV, SARS-CoV-2 and other enveloped viruses, as well as other microorganisms comprising cell surface proteins containing glycan residues, such as mannose.

Source: PVGPATDIS, file of 2026-04-10 (ipg251028.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
MOREHOUSE SCHOOL OF MEDICINE 105 patentsUS company or organizationAtlanta, GAMorehouse School of Medicine College or university EXACT high confidence: identical full name and state
MOREHOUSE SCHOOL OF MEDICINE Federal lobbying client EXACT high confidence: identical full name and state
MOREHOUSE SCHOOL OF MEDICINE INC Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Michael PowellDouglasville, GA37PVGPATDIS, file of 2026-04-10
Erick Vidjin' Agnih GbodossouDakar, SN5PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K36/42PVGPATDIS, file of 2026-04-10
A01NPreservation of bodies of humans or animals or plants or parts thereof ; biocides, e.g. as disinfectants, as pesticides or as herbicides ; pest repellants or attractants; plant growth regulatorsA01N63/50PVGPATDIS, file of 2026-04-10
A01PBiocidal, pest repellant, pest attractant or plant growth regulatory activity of chemical compounds or preparationsA01P1/00PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/12PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/1096PVGPATDIS, file of 2026-04-10
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixtureC12P19/34PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K2319/01PVGPATDIS, file of 2026-04-10
Y02ATechnologies for adaptation to climate changeY02A50/30PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-05-03Assignment
Assignment of assignor's interest
GBODOSSOU, ERICK VIDJIN' AGNIH signed 2022-05-02
POWELL, MICHAEL signed 2022-05-02
MOREHOUSE SCHOOL OF MEDICINE ATLANTA, GA59798/614ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.